| Jun'18 | Mar'18 | Dec'17 | Sep'17 | Jun'17 | ||
|---|---|---|---|---|---|---|
Cash Flows from Operating Activities: | ||||||
Net income (loss) | ||||||
497,279 | 1,375,449 | 0 | 0 | 0 | ||
Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||||||
Interest earned on marketable securities held in Trust Account | ||||||
0 | 0 | - | - | - | ||
Unrealized (gain) loss on marketable securities held in Trust Account | ||||||
0 | 0 | - | - | - | ||
Deferred taxes | ||||||
0 | 0 | - | - | - | ||
Changes in operating assets and liabilities: | ||||||
Prepaid expenses and other current assets | ||||||
- | 0 | - | - | - | ||
Accounts payable and accrued expenses | ||||||
0 | 0 | - | - | - | ||
Accrued expenses | ||||||
- | - | - | - | 0 | ||
Income taxes payable | ||||||
0 | 0 | - | - | - | ||
Net cash used in operating activities | ||||||
0 | 0 | - | - | - | ||
Cash Flows from Investing Activities: | ||||||
Cash withdrawn from Trust Account | ||||||
0 | 0 | - | - | - | ||
Net cash provided by (used in) investing activities | ||||||
0 | 0 | - | - | - | ||
Cash Flows from Financing Activities: | ||||||
Proceeds from issuance of common stock to initial stockholder | ||||||
- | - | 0 | 0 | 0 | ||
Proceeds from promissory note - related party | ||||||
- | - | 0 | 0 | 0 | ||
Payment of offering costs | ||||||
- | - | 0 | 0 | 0 | ||
Net cash provided by financing activities | ||||||
- | - | 0 | 0 | 0 | ||
Net Change in Cash and Cash Equivalents | ||||||
0 | 0 | - | - | - | ||
Net Change in Cash and Cash Equivalents | ||||||
- | - | - | - | 0 | ||
Non-Cash investing and financing activities: | ||||||
Change in value of common stock subject to possible redemption | ||||||
0 | 0 | - | - | - | ||
Deferred underwriting fees | ||||||
- | - | - | 0 | 0 | ||